Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Saga Diagnostics AB operates a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. There are currently 3 pending office actions active for the company. These 3 pending office actions are assigned to 3 distinct examiners. The matters are being processed in 2 distinct art units, indicating that the portfolio's technical scope spans multiple specialized divisions within the office. FONSECA LOPEZ, FRANCINI ALVARENGA is the busiest examiner for the portfolio, managing 1 busiest examiner pending office action.
This 1 busiest examiner pending office action is among the 3 pending office actions currently active. With 3 distinct examiners and 2 distinct art units involved, the prosecution strategy requires managing multiple simultaneous reviews. Practitioners should be prepared for varying feedback across the 2 distinct art units, as each may have different interpretations of the underlying pharmaceutical technology. The use of 3 distinct examiners provides the company with multiple points of contact at the office, which reduces the impact of any individual examiner's specific tendencies on the overall success of the 3 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KALLAL, ROBERT JAMES | 1 | 60.0% | +32.4% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 29.6% | +37.1% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18240416 | MULTI-VECTOR DETECTION OF VARIANT SEQUENCES | KALLAL, ROBERT JAMES | — |
| 18240445 | STRUCTURAL VARIANT IDENTIFICATION | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 18240453 | DETECTION OF VARIANT ESR1 SEQUENCES | JONES, CHRISTINE MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18240416 | MULTI-VECTOR DETECTION OF VARIANT SEQUENCES | KALLAL, ROBERT JAMES | — |
| 18240445 | STRUCTURAL VARIANT IDENTIFICATION | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| Art Unit | Apps |
|---|---|
| 1683 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18240416 | MULTI-VECTOR DETECTION OF VARIANT SEQUENCES | KALLAL, ROBERT JAMES | 1683 | §101§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18240445 | STRUCTURAL VARIANT IDENTIFICATION | FONSECA LOPEZ, FRANCINI ALVARENGA | — | §101§102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18240453 | DETECTION OF VARIANT ESR1 SEQUENCES | JONES, CHRISTINE MICHELLE | 1682 | §103§112DP | Non-Final OA | — | Pending | Aug 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial